179 related articles for article (PubMed ID: 37461378)
1. Cost-Effectiveness of Group Transdiagnostic Cognitive Behavioural Therapy for Anxiety Disorders in Primary Care Settings: Economic Evaluation From the Healthcare System Perspective Over a 1-Year Time Horizon.
Vasiliadis HM; Lamoureux-Lamarche C; Chapdelaine A; Provencher MD; Norton PJ; Berbiche D; Roberge P
Can J Psychiatry; 2024 Jan; 69(1):43-53. PubMed ID: 37461378
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of transdiagnostic group cognitive behavioural therapy for anxiety disorders
Chapdelaine A; Vasiliadis HM; Provencher MD; Norton PJ; Roberge P
Psychol Med; 2023 Jan; ():1-13. PubMed ID: 36695038
[TBL] [Abstract][Full Text] [Related]
3. Moderators of the cost-effectiveness of transdiagnostic CBT for anxiety disorders over an 8-month time horizon using a net-benefit regression framework.
Chapdelaine A; Vasiliadis HM; Provencher MD; Norton PJ; Roberge P
BMC Health Serv Res; 2023 Jun; 23(1):596. PubMed ID: 37291599
[TBL] [Abstract][Full Text] [Related]
4. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
5. A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care: study protocol.
Roberge P; Provencher MD; Gosselin P; Vasiliadis HM; Gaboury I; Benoit A; Antony MM; Chaillet N; Houle J; Hudon C; Norton PJ
BMC Psychiatry; 2018 Oct; 18(1):320. PubMed ID: 30285672
[TBL] [Abstract][Full Text] [Related]
6. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome: the ACTIB randomised trial.
McCrone P; Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
BMC Gastroenterol; 2021 Jul; 21(1):276. PubMed ID: 34229619
[TBL] [Abstract][Full Text] [Related]
8. START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia.
Livingston G; Barber J; Rapaport P; Knapp M; Griffin M; Romeo R; King D; Livingston D; Lewis-Holmes E; Mummery C; Walker Z; Hoe J; Cooper C
Health Technol Assess; 2014 Oct; 18(61):1-242. PubMed ID: 25300037
[TBL] [Abstract][Full Text] [Related]
9. Group transdiagnostic cognitive-behavior therapy for anxiety disorders: a pragmatic randomized clinical trial.
Roberge P; Provencher MD; Gaboury I; Gosselin P; Vasiliadis HM; Benoît A; Carrier N; Antony MM; Chaillet N; Houle J; Hudon C; Norton PJ
Psychol Med; 2020 Dec; 52(13):1-11. PubMed ID: 33261700
[TBL] [Abstract][Full Text] [Related]
10. Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation.
Kaltenthaler E; Brazier J; De Nigris E; Tumur I; Ferriter M; Beverley C; Parry G; Rooney G; Sutcliffe P
Health Technol Assess; 2006 Sep; 10(33):iii, xi-xiv, 1-168. PubMed ID: 16959169
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of blended vs. face-to-face cognitive behavioural therapy for severe anxiety disorders: study protocol of a randomized controlled trial.
Romijn G; Riper H; Kok R; Donker T; Goorden M; van Roijen LH; Kooistra L; van Balkom A; Koning J
BMC Psychiatry; 2015 Dec; 15():311. PubMed ID: 26651478
[TBL] [Abstract][Full Text] [Related]
12. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
[TBL] [Abstract][Full Text] [Related]
13. A supported self-help for recurrent depression in primary care; An economic evaluation alongside a multi-center randomised controlled trial.
Biesheuvel-Leliefeld KEM; Bosmans JE; Dijkstra-Kersten SMA; Smit F; Bockting CLH; van Schaik DJF; van Marwijk HWJ; van der Horst HE
PLoS One; 2018; 13(12):e0208570. PubMed ID: 30566441
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness and cost-utility of an Acceptance and Commitment Therapy intervention vs. a Cognitive Behavioral Therapy intervention for older adults with anxiety symptoms: A randomized controlled trial.
Witlox M; Kraaij V; Garnefski N; Bohlmeijer E; Smit F; Spinhoven P
PLoS One; 2022; 17(1):e0262220. PubMed ID: 35081130
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of transdiagnostic group cognitive behavioural therapy versus group relaxation therapy for emotional disorders in primary care (PsicAP-Costs2): Protocol for a multicentre randomised controlled trial.
González-Blanch C; Barrio-Martínez S; Priede A; Martínez-Gómez S; Pérez-García-Abad S; Miras-Aguilar M; Ruiz-Gutiérrez J; Muñoz-Navarro R; Ruiz-Rodríguez P; Medrano LA; Prieto-Vila M; Carpallo-González M; Aguilera-Martín Á; Gálvez-Lara M; Cuadrado F; Moreno E; García-Torres F; Venceslá JF; Corpas J; Jurado-González FJ; Moriana JA; Cano-Vindel A
PLoS One; 2023; 18(3):e0283104. PubMed ID: 36928238
[TBL] [Abstract][Full Text] [Related]
16. Economic Evaluation of Concise Cognitive Behavioural Therapy and/or Pharmacotherapy for Depressive and Anxiety Disorders.
Meuldijk D; Carlier IV; van Vliet IM; van Hemert AM; Zitman FG; van den Akker-van Marle ME
J Ment Health Policy Econ; 2015 Dec; 18(4):175-83. PubMed ID: 26729009
[TBL] [Abstract][Full Text] [Related]
17. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
[TBL] [Abstract][Full Text] [Related]
18. Economic Evaluation of an Internet-Based Preventive Cognitive Therapy With Minimal Therapist Support for Recurrent Depression: Randomized Controlled Trial.
Klein NS; Bockting CL; Wijnen B; Kok GD; van Valen E; Riper H; Cuijpers P; Dekker J; van der Heiden C; Burger H; Smit F
J Med Internet Res; 2018 Nov; 20(11):e10437. PubMed ID: 30478021
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness and cost-utility evaluation of individual vs. group transdiagnostic psychological treatment for emotional disorders in primary care (PsicAP-Costs): a multicentre randomized controlled trial protocol.
Aguilera-Martín Á; Gálvez-Lara M; Cuadrado F; Moreno E; García-Torres F; Venceslá JF; Corpas J; Jurado-González FJ; Muñoz-Navarro R; González-Blanch C; Ruiz-Rodríguez P; Barrio-Martínez S; Prieto-Vila M; Carpallo-González M; Cano-Vindel A; Moriana JA
BMC Psychiatry; 2022 Feb; 22(1):99. PubMed ID: 35139809
[TBL] [Abstract][Full Text] [Related]
20. Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2017; 17(15):1-167. PubMed ID: 29213344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
